Atlas Pulse News

What changed, with source links.

Atlas Pulse monitors peptide research, safety, FDA guidance, and regulatory changes. Open a card for a plain-English read, then use the original source before changing your view.

See What Changed Add updates to Watchlist

Clinical TrialClinicalTrials.gov4 days ago

PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study

The PRISE study investigates the effectiveness of human anti-thymocyte globulin in preserving endogenous C-peptide production in individuals with Type 1 diabetes, which is a peptide-related aspect of the disease.

peptide

Related to peptides:

8/10

Read source